Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF AUSTRALIA ENDOTOXIN TESTING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL XX SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 AUSTRALIA ENDOTOXIN TESTING MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 COST ANALYSIS BREAKDOWN
8 TECHNONLOGY ROADMAP
9 INNOVATION TRACKER AND STRATEGIC ANALYSIS
9.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
9.1.1 JOINT VENTURES
9.1.2 MERGERS AND ACQUISITIONS
9.1.3 LICENSING AND PARTNERSHIP
9.1.4 TECHNOLOGY COLLABORATIONS
9.1.5 STRATEGIC DIVESTMENTS
9.2 NUMBER OF PRODUCTS IN DEVELOPMENT
9.3 STAGE OF DEVELOPMENT
9.4 TIMELINES AND MILESTONES
9.5 INNOVATION STRATEGIES AND METHODOLOGIES
9.6 RISK ASSESSMENT AND MITIGATION
9.7 FUTURE OUTLOOK
10 REGULATORY COMPLIANCE
10.1 REGULATORY AUTHORITIES
10.2 REGULATORY CLASSIFICATIONS
10.2.1 CLASS I
10.2.2 CLASS II
10.2.3 CLASS III
10.3 REGULATORY SUBMISSIONS
10.4 INTERNATIONAL HARMONIZATION
10.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
10.6 REGULATORY CHALLENGES AND STRATEGIES
11 REIMBURSEMENT FRAMEWORK
12 VALUE CHAIN ANALYSIS
13 HEALTHCARE ECONOMY
13.1 HEALTHCARE EXPENDITURE
13.2 CAPITAL EXPENDITURE
13.3 CAPEX TRENDS
13.4 CAPEX ALLOCATION
13.5 FUNDING SOURCES
13.6 INDUSTRY BENCHMARKS
13.7 GDP RATION IN OVERALL GDP
13.8 HEALTHCARE SYSTEM STRUCTURE
13.9 GOVERNMENT POLICIES
13.1 ECONOMIC DEVELOPMENT
14 AUSTRALIA ENDOTOXIN TESTING MARKET, BY PRODUCT TYPE
14.1 OVERVIEW
14.2 ENDOTOXIN DETECTION KITS & REAGENTS
14.2.1 LAL TEST REAGENTS
14.2.2 MYCOPLASMA DETECTION & REMOVAL
14.2.3 PCR MYCOPLASMA DETECTION KIT
14.2.4 MYCOPLASMA ELIMINATION COCKTAIL
14.2.5 OTHERS
14.3 INSTRUMENTS & SYSTEMS
14.3.1 SERIES TUBE READER
14.3.2 MICROPLATE READER
14.3.3 LOW ENDOTOXIN RECOVERY (LER)
14.3.4 ENDOTOXIN REMOVAL
14.3.5 LOW ENDOTOXIN RECOVERY (LER)
14.3.6 OTHERS
14.4 CONSUMABLES & ACCESSORIES
14.4.1 PIPETTE TIPS
14.4.2 MULTIWELL PLATES
14.4.3 MICROPLATES
14.4.4 TUBES
14.4.5 CAPS
14.4.6 OTHERS
14.5 ENDOTOXIN TESTING SERVICES
15 AUSTRALIA ENDOTOXIN TESTING MARKET, BY TEST TYPE
15.1 OVERVIEW
15.2 LIMULUS AMOEBOCYTE LYSATE (LAL) TEST
15.3 MONOCYTE ACTIVATION TEST (MAT) TEST
15.4 RABBIT PYROGEN TEST
15.5 RECOMBINANT FACTOR C (RFC) ASSAY
16 AUSTRALIA ENDOTOXIN TESTING MARKET, BY APPLICATION
16.1 OVERVIEW
16.2 PHARMACEUTICAL MANUFACTURING
16.2.1 ENDOTOXIN DETECTION KITS & REAGENTS
16.2.2 INSTRUMENTS & SYSTEMS
16.2.3 CONSUMABLES & ACCESSORIES
16.2.4 ENDOTOXIN TESTING SERVICES
16.3 MEDICAL DEVICE MANUFACTURING
16.3.1 ENDOTOXIN DETECTION KITS & REAGENTS
16.3.2 INSTRUMENTS & SYSTEMS
16.3.3 CONSUMABLES & ACCESSORIES
16.3.4 ENDOTOXIN TESTING SERVICES
16.4 RAW MATERIALS PRODUCTION
16.4.1 ENDOTOXIN DETECTION KITS & REAGENTS
16.4.2 INSTRUMENTS & SYSTEMS
16.4.3 CONSUMABLES & ACCESSORIES
16.4.4 ENDOTOXIN TESTING SERVICES
16.5 PACKAGING MANUFACTURE
16.5.1 ENDOTOXIN DETECTION KITS & REAGENTS
16.5.2 INSTRUMENTS & SYSTEMS
16.5.3 CONSUMABLES & ACCESSORIES
16.5.4 ENDOTOXIN TESTING SERVICES
17 AUSTRALIA ENDOTOXIN TESTING MARKET, BY METHOD
17.1 OVERVIEW
17.2 GEL CLOT ENDOTOXIN TEST
17.3 CHROMOGENIC ENDOTOXIN TEST
17.4 TURBIDIMETRIC ENDOTOXIN TEST
18 AUSTRALIA ENDOTOXIN TESTING MARKET, BY MODE OF PURCHASE
18.1 OVERVIEW
18.2 LARGE GROUP
18.3 MID AND SMALL GROUP
18.4 INDIVIDUAL
19 AUSTRALIA ENDOTOXIN TESTING MARKET, BY END USER
19.1 OVERVIEW
19.2 PHARMACEUTICAL COMPANIES
19.2.1 ENDOTOXIN DETECTION KITS & REAGENTS
19.2.2 INSTRUMENTS & SYSTEMS
19.2.3 CONSUMABLES & ACCESSORIES
19.2.4 ENDOTOXIN TESTING SERVICES
19.3 BIOTECHNOLOGY COMPANIES
19.3.1 ENDOTOXIN DETECTION KITS & REAGENTS
19.3.2 INSTRUMENTS & SYSTEMS
19.3.3 CONSUMABLES & ACCESSORIES
19.3.4 ENDOTOXIN TESTING SERVICES
19.4 MEDICAL DEVICE COMPANIES
19.4.1 ENDOTOXIN DETECTION KITS & REAGENTS
19.4.2 INSTRUMENTS & SYSTEMS
19.4.3 CONSUMABLES & ACCESSORIES
19.4.4 ENDOTOXIN TESTING SERVICES
19.5 CONTRACT RESEARCH ORGANIZATION (CRO)
19.5.1 ENDOTOXIN DETECTION KITS & REAGENTS
19.5.2 INSTRUMENTS & SYSTEMS
19.5.3 CONSUMABLES & ACCESSORIES
19.5.4 ENDOTOXIN TESTING SERVICES
19.6 CONTRACT MANUFACTURING ORGANIZATION (CMO)
19.6.1 ENDOTOXIN DETECTION KITS & REAGENTS
19.6.2 INSTRUMENTS & SYSTEMS
19.6.3 CONSUMABLES & ACCESSORIES
19.6.4 ENDOTOXIN TESTING SERVICES
19.7 ACADEMIC RESEARCH INSTITUTES
19.7.1 ENDOTOXIN DETECTION KITS & REAGENTS
19.7.2 INSTRUMENTS & SYSTEMS
19.7.3 CONSUMABLES & ACCESSORIES
19.7.4 ENDOTOXIN TESTING SERVICES
19.8 OTHERS
20 AUSTRALIA ENDOTOXIN TESTING MARKET, SWOT AND DBMR ANALYSIS
21 AUSTRALIA ENDOTOXIN TESTING MARKET, COMPANY LANDSCAPE
21.1 COMPANY SHARE ANALYSIS: GLOBAL
21.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
21.3 COMPANY SHARE ANALYSIS: EUROPE
21.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
21.5 MERGERS & ACQUISITIONS
21.6 NEW PRODUCT DEVELOPMENT & APPROVALS
21.7 EXPANSIONS
21.8 REGULATORY CHANGES
21.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
22 AUSTRALIA ENDOTOXIN TESTING MARKET, BY REGION
22.1 AUSTRALIA ENDOTOXIN TESTING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
22.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
23 AUSTRALIA ENDOTOXIN TESTING MARKET, COMPANY PROFILE
23.1 LONZA
23.1.1 COMPANY OVERVIEW
23.1.2 REVENUE ANALYSIS
23.1.3 GEOGRAPHIC PRESENCE
23.1.4 PRODUCT PORTFOLIO
23.1.5 RECENT DEVELOPMENTS
23.2 CHARLES RIVER LABORATORIES
23.2.1 COMPANY OVERVIEW
23.2.2 REVENUE ANALYSIS
23.2.3 GEOGRAPHIC PRESENCE
23.2.4 PRODUCT PORTFOLIO
23.2.5 RECENT DEVELOPMENTS
23.3 EUROFINS SCIENTIFIC
23.3.1 COMPANY OVERVIEW
23.3.2 REVENUE ANALYSIS
23.3.3 GEOGRAPHIC PRESENCE
23.3.4 PRODUCT PORTFOLIO
23.3.5 RECENT DEVELOPMENTS
23.4 DANAHER
23.4.1 COMPANY OVERVIEW
23.4.2 REVENUE ANALYSIS
23.4.3 GEOGRAPHIC PRESENCE
23.4.4 PRODUCT PORTFOLIO
23.4.5 RECENT DEVELOPMENTS
23.5 BIOMÉRIEUX SA
23.5.1 COMPANY OVERVIEW
23.5.2 REVENUE ANALYSIS
23.5.3 GEOGRAPHIC PRESENCE
23.5.4 PRODUCT PORTFOLIO
23.5.5 RECENT DEVELOPMENTS
23.6 SARTORIUS AG
23.6.1 COMPANY OVERVIEW
23.6.2 REVENUE ANALYSIS
23.6.3 GEOGRAPHIC PRESENCE
23.6.4 PRODUCT PORTFOLIO
23.6.5 RECENT DEVELOPMENTS
23.7 GENSCRIPT
23.7.1 REVENUE ANALYSIS
23.7.2 GEOGRAPHIC PRESENCE
23.7.3 PRODUCT PORTFOLIO
23.7.4 RECENT DEVELOPMENTS
23.8 MERCK KGAA
23.8.1 COMPANY OVERVIEW
23.8.2 REVENUE ANALYSIS
23.8.3 GEOGRAPHIC PRESENCE
23.8.4 PRODUCT PORTFOLIO
23.8.5 RECENT DEVELOPMENTS
23.9 STERIS PLC
23.9.1 COMPANY OVERVIEW
23.9.2 REVENUE ANALYSIS
23.9.3 GEOGRAPHIC PRESENCE
23.9.4 PRODUCT PORTFOLIO
23.9.5 RECENT DEVELOPMENTS
23.1 SGS SA
23.10.1 COMPANY OVERVIEW
23.10.2 REVENUE ANALYSIS
23.10.3 GEOGRAPHIC PRESENCE
23.10.4 PRODUCT PORTFOLIO
23.10.5 RECENT DEVELOPMENTS
23.11 THERMOFISHER SCIENTIFIC, INC.
23.11.1 COMPANY OVERVIEW
23.11.2 REVENUE ANALYSIS
23.11.3 GEOGRAPHIC PRESENCE
23.11.4 PRODUCT PORTFOLIO
23.11.5 RECENT DEVELOPMENTS
23.12 ACON LABORATORIES, INC
23.12.1 COMPANY OVERVIEW
23.12.2 REVENUE ANALYSIS
23.12.3 GEOGRAPHIC PRESENCE
23.12.4 PRODUCT PORTFOLIO
23.12.5 RECENT DEVELOPMENTS
23.13 BIOMERIEUX S.A.
23.13.1 COMPANY OVERVIEW
23.13.2 REVENUE ANALYSIS
23.13.3 GEOGRAPHIC PRESENCE
23.13.4 PRODUCT PORTFOLIO
23.13.5 RECENT DEVELOPMENTS
23.14 ACCU REFERENCE MEDICAL LABS
23.14.1 COMPANY OVERVIEW
23.14.2 REVENUE ANALYSIS
23.14.3 GEOGRAPHIC PRESENCE
23.14.4 PRODUCT PORTFOLIO
23.14.5 RECENT DEVELOPMENTS
23.15 MILLENIUM HEALTH
23.15.1 COMPANY OVERVIEW
23.15.2 REVENUE ANALYSIS
23.15.3 GEOGRAPHIC PRESENCE
23.15.4 PRODUCT PORTFOLIO
23.15.5 RECENT DEVELOPMENTS
23.16 AVELLINO LABS
23.16.1 COMPANY OVERVIEW
23.16.2 REVENUE ANALYSIS
23.16.3 GEOGRAPHIC PRESENCE
23.16.4 PRODUCT PORTFOLIO
23.16.5 RECENT DEVELOPMENTS
23.17 XCR DIAGNOSTICS
23.17.1 COMPANY OVERVIEW
23.17.2 REVENUE ANALYSIS
23.17.3 GEOGRAPHIC PRESENCE
23.17.4 PRODUCT PORTFOLIO
23.17.5 RECENT DEVELOPMENTS
23.18 CTK BIOTECH, INC.
23.18.1 COMPANY OVERVIEW
23.18.2 REVENUE ANALYSIS
23.18.3 GEOGRAPHIC PRESENCE
23.18.4 PRODUCT PORTFOLIO
23.18.5 RECENT DEVELOPMENTS
23.19 ANP TECHNOLOGIES, INC.
23.19.1 COMPANY OVERVIEW
23.19.2 REVENUE ANALYSIS
23.19.3 GEOGRAPHIC PRESENCE
23.19.4 PRODUCT PORTFOLIO
23.19.5 RECENT DEVELOPMENTS
24 RELATED REPORTS
25 CONCLUSION
26 QUESTIONNAIRE
27 ABOUT DATA BRIDGE MARKET RESEARC
